Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001331021 | SCV001522919 | likely pathogenic | Intellectual disability, autosomal dominant 27 | 2019-09-06 | criteria provided, single submitter | clinical testing | This variant was determined to be likely pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. |
Revvity Omics, |
RCV001331021 | SCV002023612 | likely pathogenic | Intellectual disability, autosomal dominant 27 | 2020-12-07 | criteria provided, single submitter | clinical testing | |
SIB Swiss Institute of Bioinformatics | RCV001331021 | SCV003839022 | likely pathogenic | Intellectual disability, autosomal dominant 27 | 2023-03-09 | criteria provided, single submitter | curation | This variant is interpreted as likely pathogenic for Intellectual developmental disorder with microcephaly and with or without ocular malformations or hypogonadotropic hypogonadism, autosomal dominant. The following ACMG Tag(s) were applied: Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium (PM2); Protein length changes as a result of in-frame deletions/insertions in a nonrepeat region or stop-loss variants (PM4 upgraded to strong; loss of a region necessary for transcriptional activation activity). |
Medical Genetics Lab, |
RCV001331021 | SCV004031487 | pathogenic | Intellectual disability, autosomal dominant 27 | no assertion criteria provided | clinical testing |